immune system
• accumulation of mature T cells in the thymus without changes in other thymic subsets
|
• mice exhibit a reduction in NK cell egression from the peripheral lymph nodes compared with wild-type mice
|
• accumulation of mature T cells in the thymus without changes in other thymic subsets
|
• blood and lymph B cell counts are significantly lower than controls
• however, the number of B cells in the spleen and lymph node is normal
|
• in the spleen and lymph
|
• in bone marrow and slightly in the lymph nodes
|
• mice treated with polyinosine polycytidylic acid at P3 - 5 display markedly reduced T cell number in blood and lymph
• however, spleen and lymph node T cell numbers are normal
|
• undetectable levels of sphingosine-1-phosphate (S1P) in the plasma and lymph
|
hematopoietic system
• accumulation of mature T cells in the thymus without changes in other thymic subsets
|
• mice exhibit a reduction in NK cell egression from the peripheral lymph nodes compared with wild-type mice
|
• accumulation of mature T cells in the thymus without changes in other thymic subsets
|
• decrease in the number of mature B cells in the bone marrow
• however, immature cell numbers are similar to controls
|
• blood and lymph B cell counts are significantly lower than controls
• however, the number of B cells in the spleen and lymph node is normal
|
• in the spleen and lymph
|
• in bone marrow and slightly in the lymph nodes
|
• mice treated with polyinosine polycytidylic acid at P3 - 5 display markedly reduced T cell number in blood and lymph
• however, spleen and lymph node T cell numbers are normal
|
endocrine/exocrine glands
• accumulation of mature T cells in the thymus without changes in other thymic subsets
|
cardiovascular system
hemorrhage
(
J:205423
)
• after ovalbumin and CFA challenge, pIpC-treated mice exhibit bleeding in the draining peripheral lymph nodes and increased permeability to FITC-dextran unlike control mice
• however, pIpC-treated mice do not exhibit spontaneous bleeding into mucosal lymph nodes
|
• after ovalbumin and CFA challenge, pIpC-treated mice exhibit bleeding in the draining peripheral lymph nodes and increased permeability to FITC-dextran unlike control mice
• however, pIpC-treated mice do not exhibit spontaneous bleeding into mucosal lymph nodes and transfusion with wild-type platelets reduces vascular leakage of FITC-dextran
|